Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


Canada’s Decision To Make Public More Clinical Trial Data Puts Pressure On FDA

External Link - Source: National Public Radio

Last March, Canada’s department of health changed the way it handles the huge amount of data that companies submit when seeking approval for a new drug, biological treatment, or medical device — or a new use for an existing one. For the first time, Health Canada is making large chunks of this information publicly available after it approves or rejects applications.

This entry was posted in Health Regulation & Law, Pharmaceuticals. Bookmark the permalink.